TB
The startup develops an artificial intelligence model that predicts microbial guilds using a bio-flux metabolic framework, focusing on metabolic pathways like glucose and fructose. This technology provides medical researchers with precise insights into microbiome interactions, facilitating advancements in precision medicine related to cardiovascular health and sleep.
Updated 18 months ago
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NI
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops an artificial intelligence model that predicts microbial guilds using a bio-flux metabolic framework, focusing on metabolic pathways like glucose and fructose. This technology provides medical researchers with precise insights into microbiome interactions, facilitating advancements in precision medicine related to cardiovascular health and sleep.